Literature DB >> 18363179

Transient myeloproliferative disorder and eosinophilic pericardial effusion in a down syndrome neonate.

Rathika D Shenoy1, Kamalakshi G Bhat, Nutan Kamath, Yusuf Kumble.   

Abstract

Transient myeloproliferative disorder seen in neonates with Down syndrome is often thought to have a benign course. The authors describe the clinical and laboratory profile of a neonate with Down phenotype and transient myeloproliferative disorder with pericardial effusion as co-morbidity. Pericardial fluid analysis showed eosinophils. Pericardial effusion resolved with prednisolone therapy. Regression in hepatosplenomegaly with clearance of blasts was seen by third week of illness. The clinical course suggested a benign infiltration of the pericardium. Presence of eosinophils supports the differentiating capability of the blast cells in transient myeloproliferative disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363179     DOI: 10.1080/08880010801888220

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  4 in total

1.  Transient leukemia in down syndrome: report of two cases with review of literature.

Authors:  Alka V Gosavi; Prashant S Murarkar; Dhaneshwar N Lanjewar; Ravishankar V Ravikar
Journal:  Indian J Hematol Blood Transfus       Date:  2011-06-21       Impact factor: 0.900

2.  A dysmorphic newborn with petechiae and a 'Big Heart'.

Authors:  Ling Zhi Bernice Oh; Peng Mei Yvonne Ng; Thuan Chong Quah
Journal:  BMJ Case Rep       Date:  2014-04-04

3.  Regulator of calcineurin 1 (Rcan1) is required for the development of pulmonary eosinophilia in allergic inflammation in mice.

Authors:  Yong Jun Yang; Adam J Macneil; Robert Junkins; Svetlana O Carrigan; Jin-Tian Tang; Nicholas Forward; David Hoskin; Jason N Berman; Tong-Jun Lin
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

4.  Fetal/Neonatal Pericardial Effusion in Down's Syndrome: Case Report and Review of Literature.

Authors:  Pramod Pharande; Kiran Kumar Balegar Virupakshappa; Bhavesh Mehta; Nadia Badawi
Journal:  AJP Rep       Date:  2018-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.